Figure 2From: Comparison of zotarolimus-eluting and sirolimus-eluting coronary stents: a study from the Western Denmark Heart Registry Safety Outcomes of ZES and SES in the Western Denmark Heart Registry. Risk of all-cause mortality (A), cardiac mortality (B), late (>30 days) myocardial infarction (C), and stent thrombosis (D) among patients treated with ZES or SES.Back to article page